Drug search by name
Canakinumab Subcutaneous and Remifentanil Intravenous
Determining the interaction of Canakinumab Subcutaneous and Remifentanil Intravenous and the possibility of their joint administration.
Check result:
Canakinumab Subcutaneous <> Remifentanil Intravenous
Relevance: 24.10.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Canakinumab Subcutaneous
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Remifentanil Intravenous
Generic Name: remifentanil
Brand name: Ultiva
Synonyms: Remifentanil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Canakinumab Subcutaneous-Reminyl
- Canakinumab Subcutaneous-Reminyl ER
- Canakinumab Subcutaneous-Remodulin
- Canakinumab Subcutaneous-Remodulin injection
- Canakinumab Subcutaneous-Remular-S
- Canakinumab Subcutaneous-Renacidin
- Remifentanil Intravenous-Canasa
- Remifentanil Intravenous-Canasa Pac rectal
- Remifentanil Intravenous-Canasa rectal
- Remifentanil Intravenous-Cancidas
- Remifentanil Intravenous-Candesartan
- Remifentanil Intravenous-Candesartan and Hydrochlorothiazide
Doktika World
Interaction with food and lifestyle
Disease interaction